Thanks for that post heraclitus. I think David hit the main crux...

Thanks for that post heraclitus. I think David hit the main crux of monetizing the platform issue with his comment:

"I have to say there are a large number of people on complex medication regimes for whom this app would seem to be very useful. The issue will be to get the necessary technology into the hands of those who need it and to then train and educate them to use it effectively.

Considering we still have an aged population who are not as tech savvy as the younger generation, this will need to be made simpler or training provided for them. In addition it would nice to see it multilingual. All in all though, this has an amazing future if they get it into the right hands, at the right time and with the right price and ease of use.

I am a holder rather than trader, so I look forward to see how it plays out.